HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis.

Abstract
Prolonged contact with nanomole to micromole concentrations of the tumor promoter phorbol myristate acetate causes a significant reduction in the lytic activity of cloned cytolytic T cells. Diminished lysis is apparent even in the presence of agglutinating lectins. PMA does not exert this effect by minimizing clone viability. In fact, these concentrations of PMA cause significant potentiation of antigen-driven proliferation for many of these same clones. The PMA-mediated loss of cytolysis is reversible. Although contact with antigen does not induce or enhance reexpression of cytolysis, PMA-treated cytolytic T cell clones display normal cytolytic activity after contact with lymphokines.
AuthorsC G Orosz, D C Roopenian, F H Bach
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 130 Issue 6 Pg. 2499-501 (Jun 1983) ISSN: 0022-1767 [Print] United States
PMID6602165 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Isoantigens
  • Phorbols
  • Tetradecanoylphorbol Acetate
Topics
  • Animals
  • Clone Cells (immunology)
  • Cytotoxicity, Immunologic (drug effects)
  • Female
  • Isoantigens (immunology)
  • Lymphocyte Activation (drug effects)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Phorbols (pharmacology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Tetradecanoylphorbol Acetate (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: